INSM1
Basic information
Region (hg38): 20:20368104-20370949
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INSM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 38 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 2 | 1 |
Variants in INSM1
This is a list of pathogenic ClinVar variants found in the INSM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-20368297-C-A | not specified | Uncertain significance (Nov 24, 2024) | ||
20-20368304-T-G | not specified | Uncertain significance (Jul 09, 2021) | ||
20-20368347-A-G | not specified | Uncertain significance (May 05, 2023) | ||
20-20368383-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
20-20368395-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
20-20368428-C-A | not specified | Uncertain significance (Dec 02, 2022) | ||
20-20368447-G-A | Benign (Dec 26, 2018) | |||
20-20368502-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
20-20368505-C-A | not specified | Uncertain significance (Jan 07, 2022) | ||
20-20368506-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
20-20368511-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
20-20368526-C-T | not specified | Uncertain significance (Apr 06, 2023) | ||
20-20368557-C-G | not specified | Uncertain significance (Jan 08, 2025) | ||
20-20368574-A-T | not specified | Uncertain significance (Feb 28, 2023) | ||
20-20368686-G-A | not specified | Uncertain significance (Jan 27, 2025) | ||
20-20368689-G-T | not specified | Uncertain significance (Aug 17, 2021) | ||
20-20368739-G-T | not specified | Uncertain significance (Feb 25, 2025) | ||
20-20368743-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
20-20368776-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
20-20368776-G-T | not specified | Uncertain significance (Apr 15, 2024) | ||
20-20368796-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
20-20368827-C-A | not specified | Uncertain significance (Jul 09, 2024) | ||
20-20368827-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
20-20368862-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
20-20368872-C-G | not specified | Uncertain significance (Dec 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INSM1 | protein_coding | protein_coding | ENST00000310227 | 1 | 2826 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.269 | 0.709 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.12 | 146 | 189 | 0.771 | 0.00000907 | 3110 |
Missense in Polyphen | 12 | 16.083 | 0.74615 | 259 | ||
Synonymous | -0.335 | 93 | 89.0 | 1.05 | 0.00000455 | 1130 |
Loss of Function | 1.92 | 2 | 7.78 | 0.257 | 3.35e-7 | 124 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific DNA-binding transcriptional regulator that plays a key role in neurogenesis and neuroendocrine cell differentiation during embryonic and/or fetal development. Binds to the consensus sequence 5'-[TG][TC][TC][TT][GA]GGG[CG]A-3' in target promoters. Acts as a transcriptional repressor of NEUROD1 and INS expression via its interaction with cyclin CCND1 in a cell cycle-independent manner. Negatively regulates skeletal muscle- specific gene expression in endocrine cells of the pituitary by inhibiting the Notch signaling pathway. Represses target gene transcription by recruiting chromatin-modifying factors, such as HDAC1, HDAC2, HDAC3, KDM1A and RCOR1 histone deacetylases. Binds to its own promoter, suggesting autoregulation as a self-control feedback mechanism. Promotes the generation and expansion of neuronal basal progenitor cells in the developing neocortex. Involved in the differentiation of endocrine cells of the developing anterior pituitary gland, of the pancreas and intestine, and of sympatho-adrenal cells in the peripheral nervous system. Promotes cell cycle signaling arrest and inhibition of cellular proliferation. {ECO:0000269|PubMed:11842116, ECO:0000269|PubMed:16511571, ECO:0000269|PubMed:16569215, ECO:0000269|PubMed:18417529, ECO:0000269|PubMed:19124461}.;
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- hipred_score
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.635
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Insm1
- Phenotype
- respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype; taste/olfaction phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- insm1a
- Affected structure
- retinal bipolar neuron
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;negative regulation of protein phosphorylation;type B pancreatic cell differentiation;pancreatic A cell differentiation;type B pancreatic cell development;noradrenergic neuron development;cell cycle;negative regulation of cell population proliferation;regulation of gene expression;positive regulation of cell migration;endocrine pancreas development;norepinephrine biosynthetic process;regulation of protein complex assembly;positive regulation of cell differentiation;transdifferentiation;adrenal chromaffin cell differentiation;sympathetic ganglion development;positive regulation of cell cycle arrest;positive regulation of neural precursor cell proliferation
- Cellular component
- nucleus;nucleoplasm;transcriptional repressor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;cyclin binding;chromatin DNA binding;histone deacetylase binding;metal ion binding